How a better understanding of raw materials has increased the potential for biopharmaceutical companies to understand their process variability.How a better understanding of raw materials has increased the potential for biopharmaceutical companies to understand their process variability.
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
September 9, 2026
5 min read
Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally
September 1, 2026
7 min read
Chinese biopharma leaders are returning from the West to build a more confident – and innovative – global industry, says Cyagen’s Lance Han